Cytokinetics (CYTK) had the highest return between December 26, 2023 and January 12, 2024 by a US stock with a market cap of $2B+, returning 91.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 12/26/2023 - 1/12/2024 | 91.33% |
WM Technology (MAPSW) | 12/26/2023 - 1/12/2024 | 74.67% |
Flex (FLEX) | 12/26/2023 - 1/12/2024 | 69.14% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 12/26/2023 - 1/12/2024 | 57.93% |
QXO (QXO) | 12/26/2023 - 1/12/2024 | 37.5% |
Summit Therapeutics (SMMT) | 12/26/2023 - 1/12/2024 | 31.36% |
TMC the metals (TMC) | 12/26/2023 - 1/12/2024 | 26.32% |
Oscar Health (OSCR) | 12/26/2023 - 1/12/2024 | 24.46% |
Sarepta Therapeutics (SRPT) | 12/26/2023 - 1/12/2024 | 22.96% |
Apellis Pharmaceuticals (APLS) | 12/26/2023 - 1/12/2024 | 21.51% |
Avidity Biosciences (RNA) | 12/26/2023 - 1/12/2024 | 21.13% |
GeneDx (WGS) | 12/26/2023 - 1/12/2024 | 20.79% |
Celsius (CELH) | 12/26/2023 - 1/12/2024 | 20.68% |
Organon (OGN) | 12/26/2023 - 1/12/2024 | 20.24% |
Arrowhead Pharmaceuticals (ARWR) | 12/26/2023 - 1/12/2024 | 18.74% |
Arcutis Biotherapeutics (ARQT) | 12/26/2023 - 1/12/2024 | 18.57% |
Merus (MRUS) | 12/26/2023 - 1/12/2024 | 18.55% |
Uranium Energy (UEC) | 12/26/2023 - 1/12/2024 | 18.09% |
Dave (DAVE) | 12/26/2023 - 1/12/2024 | 17.03% |
Super Micro Computer (SMCI) | 12/26/2023 - 1/12/2024 | 16.72% |
ADMA Biologics (ADMA) | 12/26/2023 - 1/12/2024 | 16.59% |
Kinsale Capital (KNSL) | 12/26/2023 - 1/12/2024 | 15.02% |
Protagonist Therapeutics (PTGX) | 12/26/2023 - 1/12/2024 | 14.96% |
Bausch Health Companies (BHC) | 12/26/2023 - 1/12/2024 | 14.8% |
Sharplink Gaming (SBET) | 12/26/2023 - 1/12/2024 | 14.29% |
